Publications by authors named "Christopher E.M. Griffiths"

Claim this Profile
I
Impact of weight-loss interventions on psoriasis severity: A systematic review and meta-analysis.
Sarah Morrow, Poppy Hawkins, Christopher E M Griffiths, Thanasis G Tektonidis, Eli Harriss

J Eur Acad Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking on palmoplantar pustulosis.
Alice Smail, Nick Dand, Xinyue Liu, , David Baudry, Christopher E M Griffiths

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood Single-Cell Transcriptomic and Proteomic Signatures of Paradoxical Eczema in Patients with Psoriasis Treated with Biologics.
Ali Al-Janabi, Paul Martin, Catherine Simpson, Hefin Rhys, Adnan R Khan, Christopher E M Griffiths

J Invest Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug survival of IL-23 and IL-17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study.
Leila Motedayen Aval, Zenas Z N Yiu, Oras A Alabas, Christopher E M Griffiths, Nick J Reynolds

J Eur Acad Dermatol Venereol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin disease in the Eastern Cape (SKINSCAPE): a Global Psoriasis Atlas point prevalence study in rural South Africa.
Alison K Wright, Rebekah Swan, Jingyuan Xu, Su M Lwin, Shir Azrielant, Christopher E M Griffiths

Br J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoriasis and the risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel, and Taiwan.
Alex M Trafford, Yochai Schonmann, Teng-Chou Chen, Alexander Egeberg, Rosa Parisi, Christopher E M Griffiths

Br J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGF β Axis.
Charles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang, Agrin Moeini, Maria A Koufaki, Christopher E M Griffiths

Cancer Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis over five years in patients living with obesity.
Mark G Lebwohl, Andrew Blauvelt, Jerry Bagel, Ranga Gogineni, Christopher E M Griffiths

Br J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking the Cycle of Psoriasis: The Role for Early Intervention.
Thomas Graier, Su M Lwin, Christopher E M Griffiths

Br J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of Psoriasis in Poland: Prevalence, Incidence, and Mortality Rates.
Joanna Bartosińska, Jacek C Szepietowski, Dorota Raczkiewicz, Christopher E M Griffiths, Darren M Ashcroft

Int J Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating changes in baseline characteristics and drug-utilization pattern in patients with moderate-to-severe psoriasis: findings from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) cohort.
Oras A Alabas, Ian Evans, Kathleen Mcelhone, Zenas Z N Yiu, Nick J Reynolds

Clin Exp Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Psoriasis Area and Severity Index (PASI) and PASI components in two phase III trials of deucravacitinib in patients with moderate to severe plaque psoriasis.
Mark Lebwohl, Melinda J Gooderham, Richard B Warren, Diamant Thaçi, Peter Foley, Christopher E M Griffiths

Clin Exp Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stromal cells as rescue therapy in biologic-refractory psoriasis: insights from a case series.
Su M Lwin, Shane Solanky, Cristiano Scottà, Chiara Giacomini, Shir Azrielant, Christopher E M Griffiths

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Grand Challenges for Skin Health Revisited: The International League of Dermatological Societies (ILDS) Skin Disease Atlases.
Suzanne H Keddie, Christopher E M Griffiths, Gregor B E Jemec, Khaled Ezzedine, Piers Allen

Br J Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tildrakizumab in patients with early- vs. late-onset psoriasis.
April W Armstrong, Andrew Blauvelt, Mark Lebwohl, Akihiko Asahina, Ranga Gogineni, Christopher E M Griffiths

Br J Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review of the Use of the WHO-5 Well-Being Index Across Different Disease Areas.
Arnau Domenech, Ismail Kasujee, Volker Koscielny, Christopher E M Griffiths

Adv Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Ugh…how do you catch that?': a qualitative study of the impact of psoriasis on social interactions.
Susan F Moschogianis, Anna Chisholm, Shane McKie, Christopher E M Griffiths, Rebecca Elliott

Clin Exp Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are psoriasis severity and comorbidities associated with diet quality? A cross-sectional analysis using UK Biobank.
Yifan Xu, Sylvia Zanesco, Ruotong Zhang, Kathryn Dalrymple, Thivi Maruthappu, Christopher E M Griffiths

Clin Nutr· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis.
Zenas Z N Yiu, Catherine H Smith, Philip Laws, Philip J Hampton, Christopher E M Griffiths

JAMA Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axis.
Charles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang, Agrin Moeini, Maria A Koufaki, Christopher E M Griffiths

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Burma Skincare Initiative Spirit of Partnership Garden: Storytelling through Horticulture.
Su M Lwin, Christopher E M Griffiths

J Invest Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between diet quality indices and psoriasis severity: results from the Asking People with Psoriasis about Lifestyle and Eating (APPLE) cross-sectional study. - CORRIGENDUM.
Sylvia Zanesco, Thiviyani Maruthappu, Christopher E M Griffiths, Kathryn V Dalrymple, Rachel Gibson

Br J Nutr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introducing dietary advice as a therapeutic tool to manage psoriasis.
Sylvia Zanesco, Thiviyani Maruthappu, Christopher E M Griffiths, Rachel Gibson, Wendy L Hall

Proc Nutr Soc· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating CD8 T cells from patients with mild-to-moderate psoriasis are functionally impaired.
Yiqiao Chen, Chiara Tontini, Isabella Tosi, Jonathan N Barker, Paola Di Meglio, Christopher E M Griffiths

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DESTINIES Study: an online Delphi study to build international consensus on the medical conditions and procedures that confer immunosuppression and their respective COVID-19 risk profiles.
Meredith Leston, José M Ordóñez-Mena, Mark Joy, F D Richard Hobbs, Simon de Lusignan, Christopher E M Griffiths

EClinicalMedicine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis